LP35840-5
Oritavancin
Active
Description
Oritavancin (INN, also known as LY333328) is a novel semi-synthetic glycopeptide antibiotic being developed for the treatment of serious Gram-positive infections. Its structure is similar to vancomycin. It is a lipoglycopeptide. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Wikipedia
Basic Part Properties
- Part Display Name
- Oritavancin
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2005-07-07
- Construct for LOINC Short Name
- Oritavancin
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP35840-5 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP35840-5
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 奥利万星 Synonyms: 万古霉素二磷酸盐衍生物; |
| fr-CA | French (Canada) | Oritavancine |
| es-ES | Spanish (Spain) | Oritavancina |
| it-IT | Italian (Italy) | Oritavancina |
| tr-TR | Turkish (Turkey) | Oritavansin |
| ru-RU | Russian (Russian Federation) | Оритаванцин |
| nl-NL | Dutch (Netherlands) | oritavancine |
| fr-BE | French (Belgium) | Oritavancine |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright